Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
129
-
Total shares
-
22.3M
-
Shares change
-
+550K
-
Total reported value, excl. options
-
$471M
-
Value change
-
+$11.7M
-
Number of buys
-
71
-
Number of sells
-
-53
-
Price
-
$21.11
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2019
125 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2019.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 50.5M outstanding shares and own 44.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.93M shares), VANGUARD GROUP INC (2.38M shares), DIMENSIONAL FUND ADVISORS LP (1.82M shares), FEDERATED INVESTORS INC /PA/ (1.63M shares), STATE STREET CORP (1.09M shares), RENAISSANCE TECHNOLOGIES LLC (588K shares), NUVEEN ASSET MANAGEMENT, LLC (575K shares), GEODE CAPITAL MANAGEMENT, LLC (484K shares), NORTHERN TRUST CORP (480K shares), and Bank of New York Mellon Corp (390K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.